HotSpot Therapeutics
HotSpot Therapeutics develops allosteric therapies that target regulatory sites on proteins.
$100M Series B+ ·
Led by Pivotal bioVenture Partners · Source: fundraisingfox.com
Total raised: $210M across 3 sourced rounds
All 3 rounds ↓Signals
About HotSpot Therapeutics
It uses a therapy platform to discover medicines for cancer, metabolic, and rare diseases. The company leverages a database of hotspot structures and data science in its drug discovery approach.
HotSpot Therapeutics | 650 days from website to first raise on record
Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | $100M | fundraisingfox.com | ||
| Series B+ | $65M | finsmes.com | ||
| Series A | $45M | pehub.com |
Timeline
- X account created
- Website created
Founders and team
GH
Geraldine Harriman FounderJM
Jonathan Montagu Founder- DDDavid Diller Director of Computational Chemistry
AO
Alison O'Neill CMOEJ
Eva Jack Chief Operating OfficerNG
Niti Goel Chief Medical OfficerPT
Paul Thibodeau Chief Business Officer
Acquisitions
| Acquired company | Price | Announced |
|---|---|---|
| Not disclosed publicly | Date not given |
Investors
AAtlas Venturelead investor
BB Capital
BBrace Pharma
CCaaS Capital Management
LLSP BioVentures
MMonashee Investment Management
MMRL Ventures Fund
PPavilion Capital
PPivotal bioVenture Partnerslead investor
RRevelation Partners
SSofinnova Partnerslead investor
SSolasta Ventures
SSR Onelead investor
TTekla Capital Management
Companies like HotSpot Therapeutics
AActio Biosciences$66M Series B+ · Jun 2025
MMirador Therapeutics$250M Series B+ · Jan 2026
SSentinal4DPre Seed · Dec 2024AAtavistik Bio$40M Series B+ · Mar 2026
AAddition Therapeutics$100M Series A · Dec 2025
NNormunity$75M Series B+ · Jan 2025
Other companies backed by Pivotal bioVenture Partners
EEstuary Biotherapeutics$103M Series A · Oct 2026
NNeuShen Therapeutics$80M Series B+ · Sep 2026
AArkuda Therapeutics$64M Series B+ · Feb 2022
WWindward BioSeries A · May 2026
Pivotal bioVenture Partners portfolio →
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/hotspot-therapeutics (get a free API key).